![](/img/cover-not-exists.png)
Dual agonist SurrobodyTM simultaneously activates death receptors DR4 and DR5 to induce cancer cell death
Milutinovic, S., Kashyap, A. K., Yanagi, T., Wimer, C., Zhou, S., O' Neil, R., Kurtzman, A. L., Faynboym, A., Xu, L., Hannum, C. H., Diaz, P. W., Matsuzawa, S.-i., Horowitz, M., Horowitz, L., Bhatt, RLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0400
Date:
October, 2015
File:
PDF, 1.54 MB
english, 2015